DOCSLIB.ORG

Genetic Association of GDF5, COG5 and CYBA Gene Polymorphisms

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Genetic Association of GDF5, COG5 and CYBA Gene Polymorphisms Research Article iMedPub Journals Genetics and Molecular Biology Research 2018 http://www.imedpub.com/ Vol.1 No.1:5 Genetic Association of GDF5, COG5 and CYBA Gene Polymorphisms with Primary Knee Osteoarthritis in South Indian Population 1* Poornima S1 , Subramanyam K2, Khan IA3, Sumanlatha G4 , Hasan Q 1Department of Genetics and Molecular Medicine, Kamineni Hospitals, Hyderabad, Telangana, India. 2Department of Orthopedics, Yashoda Hospitals, Hyderabad, Telangana, India. 3Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia. 4Department of Genetics, Osmania University, Hyderabad, Telangana, India. *Corresponding author: Dr. Qurratulain Hasan, Department of Genetics & Molecular Medicine, Kamineni Hospitals, LB Nagar, Hyderabad 500068, India, Tel: 040-39879999; E-mail: [email protected] Received date: February 24, 2018; Accepted date: March 22, 2017; Published date: April 03, 2018 Copyright: © 2018 Poornima S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. the disability caused by the disease. To the best of our knowledge this is the first study in India. Abstract Purpose: Osteoarthritis (OA) is also known as degenerative Keywords: Osteoarthritis; GDF5; COG5; CYBA; South arthritis and it affects millions of people and can have a Indian population huge impact on their lives. Single Nucleotide Polymorphisms (SNPs) in combination with genome wide association studies (GWAS) have been significantly focused. Abbreviations: GWAS have been evaluated using candidate genes with genetic variants for Growth Differentiation Factor 5 (GDF5), OA-Osteoarthritis; GWAS-Genome-Wide Association Studies ; Component of Oligomeric Golgi complex 5 (COG5), and GDF5-Growth Differentiation Factor 5; COG5-Component of an Cytochrome B-245 alpha chain (CYBA) with primary knee Oligomeric Complex; CYBA- Cytochrome B-245 Alpha Chain; Osteoarthritis (OA). These studies have been documented in SNPs-Single Nucleotide Polymorphisms; BMI-Body Mass Index; Caucasian population, and we aimed to investigate the CDMP1-Cartilage-Derived Morphogenetic Protein 1; PCR- case-control study to evaluate association between knee OA in the South Indian population. Polymerase Chain Reaction; RFLP-Restriction Fragment Length Polymorphism; MDR-Multifactor Dimensionality Reduction; OR- Materials & methods: SNPs for GDF5 (rs143383), COG5 Odds ratio; CI-Confidence Intervals; T2DM-Type 2 Diabetes (rs4730250) and CYBA (rs4676) were genotyped with Mellitus. polymerase chain reaction and restriction fragment length polymorphism in 150 primary Knee OA cases and 150 age and gender-matched controls. Alleles and genotype Introduction frequencies were calculated to compare the significant and Knee Osteoarthritis is commonly documented form for knee non-significant association with the p-values. Multifactor dimensionality reduction (MDR) analysis was performed to joint diseases in all the ages and considered mainly in the study the gene-gene and gene-environment interactions. middle-age [1]. Osteoarthritis (OA) is one of the multifactorial diseases linked up with age and characterized through the loss Results: Baseline clinical details such as Body Mass Index of articular cartilage in synovial joints [2]. OA is the leading (BMI), weight, histories of Type 2 diabetes and hypertension cause of chronic disability, in the elderly population and is were significantly associated with primary Knee OA characterized by joint pain, swelling, stiffness and is known for (p<0.05). Genetic factors for 3 SNPs were significantly its association with poor quality of life [3,4]. The exact associated with allelic frequency, dominant, and recessive mode of inheritance pattern (p<0.05). MDR analysis mechanisms responsible in the etiology of OA are still unclear, revealed a strong synergistic interaction between GDF5 and and multiple lifestyle and environmental factors are considered CYBA as well as COG5 and CYBA gene polymorphisms. GDF5 to significantly contribute to its risk. Age, weight, climate and gene polymorphism is also synergistically interacting with economic status etc [5,6]. The increasing obesity is a growing BMI. burden in the elderly population because the knee joint is commonly affected by OA [2,7]. The results of heritability Conclusion: The three gene polymorphisms of GDF5, COG5 studies in twins, sibling pairs, and families have shown that and CYBA could be used as a molecular biomarker to genetic factors are estimated to contribute 50% of the risk for identify primary Knee OA in south Indian population to assess the risk of disease which in turn helps us to reduce developing OA [8,9]. The role of specific genes is under investigation as the estimated heritability of primary OA is high, © Under License of Creative Commons Attribution 3.0 License | This article is available from: http://www.imedpub.com/genetics-molecular-biology-research/ 1 Genetics and Molecular Biology Research 2018 Vol.6 No.1:5 i.e., 40% for the knee, 60% for the hip, and 65% for the hand superoxide, which is important for the microbicidal activity of [10]. these cells [20]. Presently, there are no pharmacological interventions for OA patients. Replacement of knee joint is the The investigations using Genome-Wide Association Studies only effective treatment at a severe stage of the osteoarthritis (GWAS) have provided significant growth in the knowledge of but is relatively costly and highly invasive. Based on the previous genetics in OA [11,12], and multiple genes have been identified studies, we assume that multiple genes may be involved in which are associated with complex diseases. Apart from GWAS, susceptibility to knee OA and we designed a case-control study meta-analysis, linkage analysis, and candidate gene studies also to evaluate the association between primary knee OA in South implicated some genes in the etiology of OA [13]. In the present Indian population with three selected SNPs relevant in the case-control study, three genes which play a role in the pathogenesis of knee OA. pathophysiology of knee OA were evaluated. Growth Differentiation Factor 5 (GDF5; ID-8200, MIM-601146), gene variant (rs143383), mapped to the gene cluster on chromosome Materials and Methods 7 which includes the component of Oligomeric Golgi complex 5 (COG5; ID-10466, MIM-606821) gene and rs4676 (C242T) Sample selection polymorphism is appeared as a functional variant in the promoter region of Cytochrome B-245, Alpha Polypeptide The present case-control study comprised 150 primary Knee (CYBA; ID-1535; MIM-608508) have been identified as candidate OA cases which were clinically diagnosed, age and gender- genes for primary knee OA [14]. The GDF5 mutation has been matched 150 individuals with no musculoskeletal problems were associated with skeletal dysplasia’s, including Hunter-Thompson- considered as controls. Approval for the study was granted by type acromesomelic dysplasia, type C brachydactyly, and Grebe- the Institutional Ethics committee as per the 1964 Helsinki type chondrodysplasia in the humans and these associations declaration and its later amendments or comparable ethical endorse that GDF5 plays an important role in human skeletal standards. After obtaining the signed informed consent from all development and maintenance [15]. GDF5 is also known as the subjects, 2 ml of peripheral blood sample was drawn in EDTA CDMP1 (cartilage-derived morphogenetic protein1), a growth vacutainer. Demographic details, along with clinical, personnel factor with high articular cartilage and a member of BMP (bone and family history were obtained from patient or patient’s care morphogenetic protein) family of the Transforming Growth taker. In this hospital-based study, we have selected 150 primary Factor β superfamily. The GDF5 is involved in the joint formation knee OA cases from the Department of Orthopedics based on and expressed in the region of future joints during early the inclusion and exclusion criteria described in our recent development. The role of GDF5 in the pathogenesis of OA is publication [21]. The primary knee OA cases were clinically known as it plays a key role in bone and cartilage diagnosed and radiologically confirmed with primary morphogenesis, as well as, in joint formation [16]. The rs143383 osteoarthritis as per the Kellegren/Lawrence score (0-4 score) polymorphism in the 5’-untranslated regions of GDF5 is [22]. associated with knee OA in Europeans and Asians [17,18]. The Simultaneously, we have selected age, and gender-matched COG5 protein is one of eight proteins (Cog1-8) which form a 150 controls from master health checkup based on Golgi-localized complex required for normal Golgi morphology questionnaire without any history of musculoskeletal diseases. and function. The encoded protein is organized with conserved The selection, inclusion and exclusion criteria of cases and oligomeric Golgi complex components 6,7 and eight into a sub- controls have been described in detail in our prior publication complex referred to as lobe B. Alternative splicing results in [23]. multiple transcript variants. Mutations in this gene result in congenital disorder of glycosylation type 2I [19]. CYBA gene Selection of SNPs encodes the light, alpha subunit which has been proposed as a primary component of the microbicidal oxidase system of In the current study, three gene
Load more

Recommended publications
  • Congenital Disorders of Glycosylation from a Neurological Perspective
    brain sciences Review Congenital Disorders of Glycosylation from a Neurological Perspective Justyna Paprocka 1,* , Aleksandra Jezela-Stanek 2 , Anna Tylki-Szyma´nska 3 and Stephanie Grunewald 4 1 Department of Pediatric Neurology, Faculty of Medical Science in Katowice, Medical University of Silesia, 40-752 Katowice, Poland 2 Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland; [email protected] 3 Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, W 04-730 Warsaw, Poland; [email protected] 4 NIHR Biomedical Research Center (BRC), Metabolic Unit, Great Ormond Street Hospital and Institute of Child Health, University College London, London SE1 9RT, UK; [email protected] * Correspondence: [email protected]; Tel.: +48-606-415-888 Abstract: Most plasma proteins, cell membrane proteins and other proteins are glycoproteins with sugar chains attached to the polypeptide-glycans. Glycosylation is the main element of the post- translational transformation of most human proteins. Since glycosylation processes are necessary for many different biological processes, patients present a diverse spectrum of phenotypes and severity of symptoms. The most frequently observed neurological symptoms in congenital disorders of glycosylation (CDG) are: epilepsy, intellectual disability, myopathies, neuropathies and stroke-like episodes. Epilepsy is seen in many CDG subtypes and particularly present in the case of mutations
    [Show full text]
  • Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024
    Document downloaded from http://www.elsevier.es, day 26/09/2021. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Nº Ref Uniprot Proteína Péptidos identificados 1 P01024 CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 por 162MS/MS 2 P02751 FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 131 3 P01023 A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 128 4 P0C0L4 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 95 5 P04275 VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 81 6 P02675 FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 78 7 P01031 CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 66 8 P02768 ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 66 9 P00450 CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 64 10 P02671 FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 58 11 P08603 CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 56 12 P02787 TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 54 13 P00747 PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 48 14 P02679 FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 47 15 P01871 IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 41 16 P04003 C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 37 17 Q9Y6R7 FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 30 18 O43866 CD5L_HUMAN CD5 antigen-like OS=Homo
    [Show full text]
  • The Untold Stories of the Speech Gene, the FOXP2 Cancer Gene
    www.Genes&Cancer.com Genes & Cancer, Vol. 9 (1-2), January 2018 The untold stories of the speech gene, the FOXP2 cancer gene Maria Jesus Herrero1,* and Yorick Gitton2,* 1 Center for Neuroscience Research, Children’s National Medical Center, NW, Washington, DC, USA 2 Sorbonne University, INSERM, CNRS, Vision Institute Research Center, Paris, France * Both authors contributed equally to this work Correspondence to: Yorick Gitton, email: [email protected] Keywords: FOXP2 factor, oncogene, cancer, prognosis, language Received: March 01, 2018 Accepted: April 02, 2018 Published: April 18, 2018 Copyright: Herrero and Gitton et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT FOXP2 encodes a transcription factor involved in speech and language acquisition. Growing evidence now suggests that dysregulated FOXP2 activity may also be instrumental in human oncogenesis, along the lines of other cardinal developmental transcription factors such as DLX5 and DLX6 [1–4]. Several FOXP family members are directly involved during cancer initiation, maintenance and progression in the adult [5–8]. This may comprise either a pro- oncogenic activity or a deficient tumor-suppressor role, depending upon cell types and associated signaling pathways. While FOXP2 is expressed in numerous cell types, its expression has been found to be down-regulated in breast cancer [9], hepatocellular carcinoma [8] and gastric cancer biopsies [10]. Conversely, overexpressed FOXP2 has been reported in multiple myelomas, MGUS (Monoclonal Gammopathy of Undetermined Significance), several subtypes of lymphomas [5,11], as well as in neuroblastomas [12] and ERG fusion-negative prostate cancers [13].
    [Show full text]
  • Mouse Cog5 Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Cog5 Knockout Project (CRISPR/Cas9) Objective: To create a Cog5 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Cog5 gene (NCBI Reference Sequence: NM_001163126 ; Ensembl: ENSMUSG00000035933 ) is located on Mouse chromosome 12. 23 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 22 (Transcript: ENSMUST00000036862). Exon 2~5 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 2 starts from about 3.82% of the coding region. Exon 2~5 covers 12.99% of the coding region. The size of effective KO region: ~9669 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 23 Legends Exon of mouse Cog5 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 2 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of Exon 5 is aligned with itself to determine if there are tandem repeats.
    [Show full text]
  • Cog5–Cog7 Crystal Structure Reveals Interactions Essential for the Function of a Multisubunit Tethering Complex
    Cog5–Cog7 crystal structure reveals interactions essential for the function of a multisubunit tethering complex Jun Yong Haa, Irina D. Pokrovskayab, Leslie K. Climerb, Gregory R. Shimamuraa, Tetyana Kudlykb, Philip D. Jeffreya, Vladimir V. Lupashinb,c, and Frederick M. Hughsona,1 aDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544; bDepartment of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72205; and cBiological Institute, Tomsk State University, Tomsk, 634050, Russian Federation Edited by Thomas C. Südhof, Stanford University School of Medicine, Stanford, CA, and approved September 30, 2014 (received for review August 4, 2014) The conserved oligomeric Golgi (COG) complex is required, along have been structurally characterized to date (11, 14). Defining the with SNARE and Sec1/Munc18 (SM) proteins, for vesicle docking quaternary structure of the other CATCHR-family MTCs remains and fusion at the Golgi. COG, like other multisubunit tethering a major challenge. complexes (MTCs), is thought to function as a scaffold and/or The COG complex is an MTC that is essential for vesicle chaperone to direct the assembly of productive SNARE complexes transport within the Golgi apparatus and from endosomal com- at the sites of membrane fusion. Reflecting this essential role, partments to the Golgi (3). Defects in individual COG subunits mutations in the COG complex can cause congenital disorders of can lead to the aberrant distribution of glycosylation enzymes glycosylation. A deeper understanding of COG function and dys- within the Golgi and thereby to severe genetic diseases known as function will likely depend on elucidating its molecular structure. congenital disorders of glycosylation (CDGs) (17, 18).
    [Show full text]
  • Simpintlists Package
    simpIntLists Package May 20, 2021 R topics documented: simpIntLists-package . .1 ArabidopsisBioGRIDInteractionEntrezId . .4 ArabidopsisBioGRIDInteractionOfficial . .6 ArabidopsisBioGRIDInteractionUniqueId . .7 C.ElegansBioGRIDInteractionEntrezId . .9 C.ElegansBioGRIDInteractionOfficial . 11 C.ElegansBioGRIDInteractionUniqueId . 13 findInteractionList . 14 FruitFlyBioGRIDInteractionEntrezId . 16 FruitFlyBioGRIDInteractionOfficial . 18 FruitFlyBioGRIDInteractionUniqueId . 19 HumanBioGRIDInteractionEntrezId . 21 HumanBioGRIDInteractionOfficial . 22 HumanBioGRIDInteractionUniqueId . 23 MouseBioGRIDInteractionEntrezId . 24 MouseBioGRIDInteractionOfficial . 25 MouseBioGRIDInteractionUniqueId . 27 S.PombeBioGRIDInteractionEntrezId . 28 S.PombeBioGRIDInteractionOfficial . 30 S.PombeBioGRIDInteractionUniqueId . 33 YeastBioGRIDInteractionEntrezId . 35 YeastBioGRIDInteractionOfficial . 38 YeastBioGRIDInteractionUniqueId . 41 Index 46 simpIntLists-package The package contains BioGRID interactions for various organ- isms in a simple format Description The package contains BioGRID interactions for arabidopsis(thale cress), c.elegans, fruit fly, human, mouse, yeast( budding yeast ) and S.pombe (fission yeast) . Entrez ids, official names and unique ids can be used to find proteins. 1 2 simpIntLists-package Details simpIntLists-package 3 Package: simpIntLists Type: Package Version: 1.0 Date: 2011-01-18 License: GPL version 2 or newer LazyLoad: yes Author(s) Kircicegi KORKMAZ, Volkan ATALAY, Rengul CETIN ATALAY Maintainer: Kircicegi KORKMAZ <[email protected]> References
    [Show full text]
  • Prior Infection with Type a Francisella Tularensis Antagonizes The
    Walters et al. BMC Genomics (2015) 16:874 DOI 10.1186/s12864-015-2022-2 RESEARCH ARTICLE Open Access Prior infection with Type A Francisella tularensis antagonizes the pulmonary transcriptional response to an aerosolized Toll-like receptor 4 agonist Kathie-Anne Walters1*, Rachael Olsufka2, Rolf E. Kuestner1, Xiagang Wu1, Kai Wang1, Shawn J. Skerrett2 and Adrian Ozinsky1 Abstract Background: Francisella infection attenuates immune cell infiltration and expression of selected pro-inflammatory cytokines in response to endogenous LPS, suggesting the bacteria is actively antagonizing at least some part of the response to Toll-like receptor 4 (TLR4) engagement. The ability of different Francisella strains to inhibit the ability of E. coli LPS to induce a pulmonary inflammatory response, as measured by gene expression profiling, was examined to define the scope of modulation and identify of inflammatory genes/pathways that are specifically antagonized by a virulent F. tularensis infection. Results: Prior aerosol exposure to F. tularensis subsp. tularensis, but not the live attenuated strain (LVS) of F. tularensis subsp. holarctica or F. novicida, significantly antagonized the transcriptional response in the lungs of infected mice exposed to aerosolized E. coli LPS. The response to E. coli LPS was not completely inhibited, suggesting that the bacteria is targeting further downstream of the TLR4 molecule. Analysis of the promotors of LPS-responsive genes that were perturbed by Type A Francisella infection identified candidate transcription factors that were potentially modulated by the bacteria, including multiple members of the forkhead transcription factor family (FoxA1, Foxa2, FoxD1, Foxd3, Foxf2, FoxI1, Fox03, Foxq1), IRF1, CEBPA, and Mef2. The annotated functional roles of the affected genes suggested that virulent Francisella infection suppressed cellular processes including mRNA processing, antiviral responses, intracellular trafficking, and regulation of the actin cytoskeleton.
    [Show full text]
  • COG5 Variants Lead to Complex Early Onset Retinal Degeneration
    www.nature.com/scientificreports OPEN COG5 variants lead to complex early onset retinal degeneration, upregulation of PERK and DNA damage Sami Tabbarah1,2,3,4, Erika Tavares2, Jason Charish3, Ajoy Vincent1,2, Andrew Paterson2, Matteo Di Scipio2, Yue Yin2, Roberto Mendoza‑Londono5, Jason Maynes6,7, Elise Heon1,2,8* & Philippe P. Monnier1,3,4,8* Leber congenital amaurosis (LCA), a form of autosomal recessive severe early‑onset retinal degeneration, is an important cause of childhood blindness. This may be associated with systemic features or not. Here we identifed COG5 compound‑heterozygous variants in patients afected with a complex LCA phenotype associated with microcephaly and skeletal dysplasia. COG5 is a component of the COG complex, which facilitates retrograde Golgi trafcking; if disrupted this can result in protein misfolding. To date, variants in COG5 have been associated with a distinct congenital disorder of glycosylation (type IIi) and with a variant of Friedreich’s ataxia. We show that COG5 variants can also result in fragmentation of the Golgi apparatus and upregulation of the UPR modulator, PKR‑ like endoplasmic reticulum kinase (PERK). In addition, upregulation of PERK induces DNA damage in cultured cells and in murine retina. This study identifes a novel role for COG5 in maintaining ER protein homeostasis and that disruption of that role results in activation of PERK and early‑onset retinal degeneration, microcephaly and skeletal dysplasia. These results also highlight the importance of the UPR pathway in early‑onset retinal dystrophy and as potential therapeutic targets for patients. Severe retinal degeneration (RD) with early-onset and nystagmus is ofen referred to as Leber’s congenital amau- rosis (LCA), which is a genetically heterogeneous form of inherited retinal disease (IRD)1 for which gene-specifc treatments have been initiated2.
    [Show full text]
  • Gnomad Lof Supplement
    1 gnomAD supplement gnomAD supplement 1 Data processing 4 Alignment and read processing 4 Variant Calling 4 Coverage information 5 Data processing 5 Sample QC 7 Hard filters 7 Supplementary Table 1 | Sample counts before and after hard and release filters 8 Supplementary Table 2 | Counts by data type and hard filter 9 Platform imputation for exomes 9 Supplementary Table 3 | Exome platform assignments 10 Supplementary Table 4 | Confusion matrix for exome samples with Known platform labels 11 Relatedness filters 11 Supplementary Table 5 | Pair counts by degree of relatedness 12 Supplementary Table 6 | Sample counts by relatedness status 13 Population and subpopulation inference 13 Supplementary Figure 1 | Continental ancestry principal components. 14 Supplementary Table 7 | Population and subpopulation counts 16 Population- and platform-specific filters 16 Supplementary Table 8 | Summary of outliers per population and platform grouping 17 Finalizing samples in the gnomAD v2.1 release 18 Supplementary Table 9 | Sample counts by filtering stage 18 Supplementary Table 10 | Sample counts for genomes and exomes in gnomAD subsets 19 Variant QC 20 Hard filters 20 Random Forest model 20 Features 21 Supplementary Table 11 | Features used in final random forest model 21 Training 22 Supplementary Table 12 | Random forest training examples 22 Evaluation and threshold selection 22 Final variant counts 24 Supplementary Table 13 | Variant counts by filtering status 25 Comparison of whole-exome and whole-genome coverage in coding regions 25 Variant annotation 30 Frequency and context annotation 30 2 Functional annotation 31 Supplementary Table 14 | Variants observed by category in 125,748 exomes 32 Supplementary Figure 5 | Percent observed by methylation.
    [Show full text]
  • Novel Compound Heterozygous COG5 Mutations in a Chinese Male Patient with Severe Clinical Symptoms and Type Iii Congenital Disorder of Glycosylation: a Case Report
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 18: 2695-2700, 2019 Novel compound heterozygous COG5 mutations in a Chinese male patient with severe clinical symptoms and type IIi congenital disorder of glycosylation: A case report SHAOWEI YIN1-3, LIYING GONG4, HAO QIU5, YAN ZHAO6, YAN ZHANG7, CAIXIA LIU1-3, HONGKUN JIANG8, YAN MAO5, LING-YIN KONG5, BO LIANG9 and YUAN LV1-3 1Liaoning Centre for Prenatal Diagnosis, Key Laboratory of Maternal-Fetal Medicine of Liaoning Province; 2Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province; 3Department of Obstetrics and Gynecology, Shengjing Hospital Affiliated to China Medical University, Shenyang, Liaoning 110004; 4Clinical Laboratory, The People's Hospital of China Medical University, Shenyang, Liaoning 110016; 5Basecare Medical Device Co., Ltd., Suzhou, Jiangsu 215000; 6Genetics Unit; 7The Outpatient Department of Obstetrics, Shenyang Maternity and Infant's Hospital, Shenyang, Liaoning 110004; 8Department of Pediatrics, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110016; 9State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, P.R. China Received November 30, 2018; Accepted July 5, 2019 DOI: 10.3892/etm.2019.7834 Abstract. In the current study, one case of COG5-CDG Introduction involving a Chinese male patient with severe neurological symptoms, who had previously been misdiagnosed with Mutations in subunit five of the conserved oligomeric Golgi congenital gyrus malformation, is described. A clinical investi- (COG) complex gives rise to type IIi congenital disorders of gation was performed and targeted next-generation sequencing glycosylation (CDG) (1). CDG is physiologically related to (NGS) was used to identify COG5 variants in the patient and other pathologies involving glycan defects and can lead to his family.
    [Show full text]
  • An Integrated Framework for Genome Analysis Reveals Numerous Previously
    bioRxiv preprint doi: https://doi.org/10.1101/563270; this version posted February 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. An Integrated Framework for Genome Analysis Reveals Numerous Previously Unrecognizable Structural Variants in Leukemia Patients’ Samples Jie Xu1*, Fan Song1,6*, Emily Schleicher1*, Christopher Pool3, Darrin Bann3, Max Hennessy3, Kathryn Sheldon2, Emma Batchelder2, Charyguly Annageldiyev4, Arati Sharma4, Yuanyuan Chang7, Alex Hastie7, Barbara Miller5, David Goldenberg3, Shin Mineishi5, David Claxton4, George-Lucian Moldovan1, Feng Yue1,2, James R. Broach1,2 1 Department of Biochemistry and 2 Institute for Personalized Medicine Penn State College of Medicine, Hershey, PA 17033 3 Department of Otolaryngology, 4 Department of Hematology Oncology, 5Departments of Pediatrics and Medicine PennState Health, Hershey Medical Center, Hershey, PA 17033 6 Huck Institute of Life Sciences, Penn State University, State College, PA 16802 7 Bionano Genomics, 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121 *Contributed equally to the project. Corresponding author: James R. Broach [email protected] 717-531-8586 Running title: Novel leukemia structural variants 1 bioRxiv preprint doi: https://doi.org/10.1101/563270; this version posted February 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Key Words: Acute myeloid leukemia Somatic mutation Genomic structural variants Optical mapping Karyotyping Chromothripsis Allelic imbalance Patient outcomes 2 bioRxiv preprint doi: https://doi.org/10.1101/563270; this version posted February 28, 2019.
    [Show full text]
  • Chromosome-Specific and Global Effects of Aneuploidy in Saccharomyces Cerevisiae
    Genetics: Early Online, published on February 2, 2016 as 10.1534/genetics.115.185660 Chromosome-Specific and Global Effects of Aneuploidy in Saccharomyces cerevisiae Stacie E. Dodgson*,†, Sharon Kim*,†, Michael Costanzo‡, Anastasia Baryshnikova§, Darcy L. Morse†, Chris A. Kaiser†, Charles Boone‡, Angelika Amon*,† * Koch Institute for Integrative Cancer Research, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA † Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA ‡ The Donnelly Centre, University of Toronto, Toronto, ON M5S3E1, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S3E1, Canada § Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544-1014 1 Copyright 2016. Aneuploidy Synthetic Interactions Keywords: aneuploidy, synthetic lethality, dosage imbalance, protein transport Corresponding author: Angelika Amon, 77 Massachusetts Avenue 76-561, Cambridge, MA 02139; 617-258-6559; [email protected] 2 ABSTRACT Aneuploidy, an unbalanced karyotype in which one or more chromosomes are present in excess or reduced copy number, causes an array of known phenotypes including proteotoxicity, genomic instability and slowed proliferation. However, the molecular consequences of aneuploidy are poorly understood and an unbiased investigation into aneuploid cell biology is lacking. We performed high-throughput screens for genes whose deletion has a synthetic fitness cost in aneuploid Saccharomyces cerevisiae cells containing single extra chromosomes. This analysis identified genes that when deleted decrease the fitness of specific disomic strains as well as those that impair the proliferation of a broad range of aneuploidies. In one case, a chromosome-specific synthetic growth defect could be explained fully by the specific duplication of a single gene on the aneuploid chromosome, highlighting the ability of individual dosage imbalances to cause chromosome-specific phenotypes in aneuploid cells.
    [Show full text]